These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32208323)

  • 21. Cannabis expectancies in substance misusers: French validation of the Marijuana Effect Expectancy Questionnaire.
    Guillem E; Notides C; Vorspan F; Debray M; Nieto I; Leroux M; Lépine JP
    Am J Addict; 2011; 20(6):543-54. PubMed ID: 21999501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a short cannabis problems questionnaire for adolescents in the community.
    Proudfoot H; Vogl L; Swift W; Martin G; Copeland J
    Addict Behav; 2010 Jul; 35(7):734-7. PubMed ID: 20356683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric Properties of the Turkish Versions of the Cannabis Use Problems Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ).
    Evren C; Yilmaz Cengel H; Bozkurt M; Evren B; Umut G; Agachanli R
    J Psychoactive Drugs; 2017; 49(1):83-89. PubMed ID: 28195831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU).
    Cuttler C; Spradlin A
    PLoS One; 2017; 12(5):e0178194. PubMed ID: 28552942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cannabis Problems Questionnaire: factor structure, reliability, and validity.
    Copeland J; Gilmour S; Gates P; Swift W
    Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening tools for cannabis use disorders and their adaptation to DSM-5: A literature review].
    Artigaud L; Fener C; Bisch M; Schwan R; Schwitzer T; De Ternay J; Adamson SJ; Rolland B; Laprévote V
    Encephale; 2020 Oct; 46(5):382-389. PubMed ID: 32475691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.
    Loflin MJE; Kiluk BD; Huestis MA; Aklin WM; Budney AJ; Carroll KM; D'Souza DC; Dworkin RH; Gray KM; Hasin DS; Lee DC; Le Foll B; Levin FR; Lile JA; Mason BJ; McRae-Clark AL; Montoya I; Peters EN; Ramey T; Turk DC; Vandrey R; Weiss RD; Strain EC
    Drug Alcohol Depend; 2020 Jul; 212():107993. PubMed ID: 32360455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder.
    Arias AJ; Hammond CJ; Burleson JA; Kaminer Y; Feinn R; Curry JF; Dennis ML
    J Subst Abuse Treat; 2020 Oct; 117():108087. PubMed ID: 32811625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students.
    Schultz NR; Bassett DT; Messina BG; Correia CJ
    Addict Behav; 2019 Aug; 95():11-15. PubMed ID: 30798191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motivational and control mechanisms underlying adolescent cannabis use disorders: A prospective study.
    Cousijn J; van Benthem P; van der Schee E; Spijkerman R
    Dev Cogn Neurosci; 2015 Dec; 16():36-45. PubMed ID: 25922296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of the Cannabis Abuse Screening Test (CAST) in the general population.
    Legleye S; Guignard R; Richard JB; Ludwig K; Pabst A; Beck F
    Int J Methods Psychiatr Res; 2015 Jun; 24(2):170-83. PubMed ID: 26077195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring adherence and abstinence of cannabis use disorder patients: Profile identification and relationship with long-term treatment outcomes.
    Dacosta-Sánchez D; Fernández-Calderón F; Blanc-Molina A; Díaz-Batanero C; Lozano OM
    J Subst Use Addict Treat; 2023 May; 148():209019. PubMed ID: 36933660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
    Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
    Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased drinking in adults with co-occurring cannabis and alcohol use disorders in a treatment trial for marijuana dependence: Evidence of a secondary benefit?
    Dunn HK; Litt MD
    Addict Behav; 2019 Dec; 99():106051. PubMed ID: 31487577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The psychometric properties of the 5-item gratitude questionnaire in Chinese adolescents.
    Zeng Y; Ling Y; Huebner ES; He Y; Lei X
    J Psychiatr Ment Health Nurs; 2017 May; 24(4):203-210. PubMed ID: 28140495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Cannabis Abuse Screening Test in a sample of cannabis inpatients.
    Legleye S; Kraus L; Piontek D; Phan O; Jouanne C
    Eur Addict Res; 2012; 18(4):193-200. PubMed ID: 22472963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CANDIS treatment program for cannabis use disorders: findings from a randomized multi-site translational trial.
    Hoch E; Bühringer G; Pixa A; Dittmer K; Henker J; Seifert A; Wittchen HU
    Drug Alcohol Depend; 2014 Jan; 134():185-193. PubMed ID: 24176199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.